ReviewBreast cancer (Dove Medical Press)2020

Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives.

Monica Iorfida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.